Renalytix: Howard Doran

Renalytix has appointed Howard Doran a chief business officer, effective Sept. 1. He has more than 30 years of general management, strategic planning, and marketing and sales experience in the diagnostics and pharmaceutical industries. Doran was previously president and CEO of LipoScience until that firm was acquired by Labcorp in 2014. Before that, he was president and chief commercial officer of IVD firm Constitution Medical, which was acquired by Roche in 2013. Prior to that, Doran was president of Hologic's Global Diagnostics business.